Daniel L Jacoby

15PUBLICATIONS
87CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Epidemiological modellingAllergyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 08, 2026
Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.

|Dec 05, 2025
Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM.

Juan Pablo Kaski, Paul F Kantor, Stephanie J Nakano

|Sep 05, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.

Joseph Campain, Catharine Griskowitz, Chloe Newlands

|Sep 01, 2024
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial.

Caroline J Coats, Ahmad Masri, Roberto Barriales-Villa

|Apr 07, 2022
Symptom Cluster Profiles Among Adults with Insomnia and Heart Failure.

Samantha Conley, Sangchoon Jeon, Stephen Breazeale

|Apr 06, 2022
Muscle LIM Protein Force-Sensing Mediates Sarcomeric Biomechanical Signaling in Human Familial Hypertrophic Cardiomyopathy.

Pageof 3

Frequent Collaborators

4 joint publications

Stuart Kupfer

4 joint publications

Sangchoon Jeon

4 joint publications

Samantha Conley

4 joint publications

Carolyn Y Ho